CVRx Inc (CVRX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CVRx Inc (CVRX) has a cash flow conversion efficiency ratio of -0.442x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-8.83 Million) by net assets ($19.95 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CVRX market cap for the company's overall valuation and market capitalisation.
CVRx Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how CVRx Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
CVRx Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CVRx Inc ranked by their cash flow conversion efficiency. See CVRX operating cash to total liabilities to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GreenTree Hospitality Group Ltd
NYSE:GHG
|
0.036x |
|
Top High Image
TWO:3284
|
0.004x |
|
Professional Computer Technology Ltd
TWO:6270
|
0.039x |
|
Jinhui Shipping and Transportation Limited
F:J4O
|
0.024x |
|
OptimumBank Holdings, Inc.
NYSE MKT:OPHC
|
0.052x |
|
Atlantic International Corp. Common Stock
NASDAQ:ATLN
|
-0.154x |
|
Xtant Medical Holdings Inc
NYSE MKT:XTNT
|
0.106x |
|
Tailyn Technologies
TWO:5353
|
0.003x |
Annual Cash Flow Conversion Efficiency for CVRx Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of CVRx Inc from 2019 to 2025. View CVRx Inc (CVRX) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $39.32 Million | $-40.17 Million | -1.022x | -85.43% |
| 2024-12-31 | $71.06 Million | $-39.14 Million | -0.551x | -7.22% |
| 2023-12-31 | $75.95 Million | $-39.02 Million | -0.514x | -31.44% |
| 2022-12-31 | $109.18 Million | $-42.68 Million | -0.391x | -105.73% |
| 2021-12-31 | $145.96 Million | $-27.73 Million | -0.190x | -446.14% |
| 2020-12-31 | $-293.24 Million | $-16.10 Million | 0.055x | +19.80% |
| 2019-12-31 | $-279.04 Million | $-12.79 Million | 0.046x | -- |
About CVRx Inc
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased … Read more